Swedish Orphan Biovitrum

News Swedish Orphan Biovitrum

• FDA approves Kineret for the treatment of NOMID

  Sobi announced that the US Food and Drug Administration (FDA) has approved Kineret® (anakinra) for the treatment of children and adults with neonatal-onset multisystem inflammatory disease (NOMID). Kineret® is the FDA-approved therapy for NOMID, the most severe form of cryopyrin associated periodic more

• Biogen Idec and Sobi announce positive top-line results from phase 3 study in hemophilia B

  Biogen Idec and Swedish Orphan Biovitrum (Sobi)announced positive results from B-LONG, a clinical study that evaluated a new long-lasting clotting factor candidate in people with hemophilia B. Hemophilia B is a rare inherited disorder that impairs blood coagulation.Top-line results from B-LONG, a gl more

• Biogen Idec and Sobi Initiate Global Clinical Trials of Long-Lasting Hemophilia A and B Product Candidates in Children

  Biogen Idec and Swedish Orphan Biovitrum announced the initiation of two global pediatric clinical trials of the companies' long-lasting recombinant Factor VIII and Factor IX Fc fusion proteins (rFVIIIFc and rFIXFc) in hemophilia A and B.rFVIIIFc and rFIXFc are fully-recombinant clotting factors dev more

Market studies Swedish Orphan Biovitrum

• New Nordic Healthbrands AB (NNH) - Financial and Strategic SWOT Analysis Review

  New Nordic Healthbrands AB (New Nordic) is a Sweden based pharmaceutical company. The company is principally engaged in development, production and distribution of food supplements and herbal remedies. The product portfolio includes apple cider, mulberry, cranberry, melissa, herbal cleaning, and oth more

Websites Swedish Orphan Biovitrum